BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 34407041)

  • 41. Lupus anticoagulant and thrombosis in splenic marginal zone lymphoma.
    Gebhart J; Lechner K; Skrabs C; Sliwa T; Müldür E; Ludwig H; Nösslinger T; Vanura K; Stamatopoulos K; Simonitsch-Klupp I; Chott A; Quehenberger P; Mitterbauer-Hohendanner G; Pabinger I; Jäger U; Geissler K
    Thromb Res; 2014 Nov; 134(5):980-4. PubMed ID: 25201005
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Splenic marginal zone lymphoma complicated by cold agglutinin disease].
    Ochi K; Yokoyama K; Ohno N; Ota Y; Tojo A
    Rinsho Ketsueki; 2017; 58(2):132-137. PubMed ID: 28321090
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Laparoscopic splenectomy for treatment of splenic marginal zone lymphoma.
    Wu Z; Zhou J; Wang X; Li YB; Niu T; Peng B
    World J Gastroenterol; 2013 Jun; 19(24):3854-60. PubMed ID: 23840125
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Splenic marginal zone lymphoma: current knowledge and future directions.
    Thieblemont C; Davi F; Noguera ME; Brière J; Bertoni F; Zucca E; Traverse-Glehen A; Felman P; Berger F; Salles G; Coiffier B
    Oncology (Williston Park); 2012 Feb; 26(2):194-202. PubMed ID: 22489356
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Progression to large B-cell lymphoma in splenic marginal zone lymphoma: a description of a series of 12 cases.
    Camacho FI; Mollejo M; Mateo MS; Algara P; Navas C; Hernández JM; Santoja C; Solé F; Sánchez-Beato M; Piris MA
    Am J Surg Pathol; 2001 Oct; 25(10):1268-76. PubMed ID: 11688461
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Identification of splenic marginal zone lymphoma from B lymphoproliferative disorders by flow cytometry].
    Hu Y; Chen Y; Wang LH; Chen X; Fang F; Liu SQ; Wu XQ; Zhu P
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):349-56. PubMed ID: 24763004
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Splenic marginal zone lymphoma: a case report and literature review.
    Zhang S; Xuan Z; Zhang L; Lu J; Song P; Zheng S
    World J Surg Oncol; 2020 Oct; 18(1):259. PubMed ID: 33004051
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Outcomes in patients with splenic marginal zone lymphoma and marginal zone lymphoma treated with rituximab with or without chemotherapy or chemotherapy alone.
    Tsimberidou AM; Catovsky D; Schlette E; O'Brien S; Wierda WG; Kantarjian H; Garcia-Manero G; Wen S; Do KA; Lerner S; Keating MJ
    Cancer; 2006 Jul; 107(1):125-35. PubMed ID: 16700034
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nodal and splenic marginal zone B cell lymphomas.
    Mollejo M; Camacho FI; Algara P; Ruiz-Ballesteros E; García JF; Piris MA
    Hematol Oncol; 2005; 23(3-4):108-18. PubMed ID: 16307458
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Significant efficacy of 2-CdA with or without rituximab in the treatment of splenic marginal zone lymphoma (SMZL).
    Cervetti G; Galimberti S; Sordi E; Buda G; Orciuolo E; Cecconi N; Petrini M
    Ann Oncol; 2010 Apr; 21(4):851-854. PubMed ID: 19825880
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Successful treatment with rituximab in a patient with splenic marginal zone B-cell lymphoma accompanied by cold agglutinin disease].
    Yasuyama M; Kawauchi K; Otsuka K; Tamura H; Fujibayashi M
    Nihon Ronen Igakkai Zasshi; 2014; 51(6):569-75. PubMed ID: 25749330
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rituximab, used alone or in combination, is superior to other treatment modalities in splenic marginal zone lymphoma.
    Else M; Marín-Niebla A; de la Cruz F; Batty P; Ríos E; Dearden CE; Catovsky D; Matutes E
    Br J Haematol; 2012 Nov; 159(3):322-8. PubMed ID: 23016878
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Idelalisib and Rituximab in 17p Deletion-Positive Splenic Marginal Zone Lymphoma.
    Philip AZ
    J Natl Compr Canc Netw; 2018 Mar; 16(3):230-233. PubMed ID: 29523661
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Marginal zone lymphomas: management of nodal, splenic, and MALT NHL.
    Kahl B; Yang D
    Hematology Am Soc Hematol Educ Program; 2008; ():359-64. PubMed ID: 19074110
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Complete remission of splenic marginal zone lymphoma after an acute flare-up of hepatitis B in a hepatitis B virus carrier.
    Fujimoto K; Endo T; Nishio M; Obara M; Yamaguchi K; Takeda Y; Goto H; Kasahara I; Sato N; Koike T
    Int J Hematol; 2009 Dec; 90(5):601-604. PubMed ID: 19802732
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The genetics of nodal marginal zone lymphoma.
    Spina V; Khiabanian H; Messina M; Monti S; Cascione L; Bruscaggin A; Spaccarotella E; Holmes AB; Arcaini L; Lucioni M; Tabbò F; Zairis S; Diop F; Cerri M; Chiaretti S; Marasca R; Ponzoni M; Deaglio S; Ramponi A; Tiacci E; Pasqualucci L; Paulli M; Falini B; Inghirami G; Bertoni F; Foà R; Rabadan R; Gaidano G; Rossi D
    Blood; 2016 Sep; 128(10):1362-73. PubMed ID: 27335277
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevalence of hepatitis B and hepatitis C viral infections in various subtypes of B-cell non-Hodgkin lymphoma: confirmation of the association with splenic marginal zone lymphoma.
    Xiong W; Lv R; Li H; Li Z; Wang H; Liu W; Zou D; Qiu L; Yi S
    Blood Cancer J; 2017 Mar; 7(3):e548. PubMed ID: 28362442
    [No Abstract]   [Full Text] [Related]  

  • 58. Bone marrow histopathology in the diagnostic evaluation of splenic marginal-zone and splenic diffuse red pulp small B-cell lymphoma: a reliable substitute for spleen histopathology?
    Ponzoni M; Kanellis G; Pouliou E; Baliakas P; Scarfò L; Ferreri AJ; Doglioni C; Bikos V; Dagklis A; Anagnostopoulos A; Ghia P; Stamatopoulos K; Papadaki T
    Am J Surg Pathol; 2012 Nov; 36(11):1609-18. PubMed ID: 23073320
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Tumors of lymphoid and hematopoietic tissue of spleen: a clinicopathologic analysis of 53 cases].
    Chen DB; Shen DH; Zhang H; Wang Y; Song QJ; Yang SM; Fang XZ
    Zhonghua Bing Li Xue Za Zhi; 2017 Nov; 46(11):775-781. PubMed ID: 29136691
    [No Abstract]   [Full Text] [Related]  

  • 60. Whole-genome sequencing identifies recurrent somatic NOTCH2 mutations in splenic marginal zone lymphoma.
    Kiel MJ; Velusamy T; Betz BL; Zhao L; Weigelin HG; Chiang MY; Huebner-Chan DR; Bailey NG; Yang DT; Bhagat G; Miranda RN; Bahler DW; Medeiros LJ; Lim MS; Elenitoba-Johnson KS
    J Exp Med; 2012 Aug; 209(9):1553-65. PubMed ID: 22891276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.